StonvexLoading…
StonvexStonvexStonvexCore line items from CTRE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.23M | $0.00 | $0.00 | $0.00 |
Operating Income | $325.29M | $124.40M | $53.72M | Not available |
Net Income | $320.54M | $125.08M | $53.73M | $-7.51M |
EPS (Diluted) | $1.57 | $0.80 | $0.50 | $-0.08 |
Total Assets | $5.15B | $3.44B | $2.08B | $1.62B |
Total Liabilities | $1.09B | $507.63M | $666.12M | $771.41M |
Cash & Equivalents | $198.04M | $213.82M | $294.45M | $13.18M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 222.75M | 186.99M | 129.99M | 99.01M |